Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanoma
New Zealand
524636
Filed on 2003-03-06
524636
Filed on 2003-03-06
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
European Patent
01968307.7
Filed on 2001-08-31
01968307.7
Filed on 2001-08-31
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
Australia
2001288562
Filed on 2001-08-31
2001288562
Filed on 2001-08-31
Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway: A Selective Therapeutic Strategy Against Melanomas
Canada
2419567
Filed on 2001-08-31
2419567
Filed on 2001-08-31
INHIBITION OF SMAD3 TO PREVENT FIBROSIS AND TO IMPROVE WOUND HEALING
US Application 11/299,122
Filed on 2005-12-09
Filed on 2005-12-09
Anthrax Lethal Factor is A MAPK Kinase Protease
US Patent 7,183,071
Filed on 2006-01-05
Filed on 2006-01-05
DAMPENING OF AN IMMUNODOMINANT EPITOPE OF AN ANTIGEN FOR USE IN PLANT, ANIMAL AND HUMAN VACCINES AND IMMUNOTHERAPIES
Japan
2005-367769
Filed on 2004-08-19
2005-367769
Filed on 2004-08-19
CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES
Sweden
95936278.1
Filed on 1995-10-06
95936278.1
Filed on 1995-10-06
CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES
Portugal
95936278.1
Filed on 1995-10-06
95936278.1
Filed on 1995-10-06